Frank Bellivier, 52
Frank Bellivier received his medical degree at the University of Paris (René Descartes). There, he also completed his residency training and a PhD in Neurosciences, before undertaking a research fellowship at Pitié-Salpêtrière Hospital, Paris. His current roles include Professor of Adult Psychiatry at University Denis Diderot in Paris, Head of the Departments of Psychiatry and Addiction at Saint-Louis - Lariboisière – F. Widal hospitals in Paris. He is also director of a research team on neuropsychopharmacology of bipolar disorders and addictions at the Institut National de la Santé et de la Recherche Médicale (INSERM UMRS_1144, www.umrs1144.com).
Professor Bellivier has led several large clinical programmes for patients with mood disorders, including the Early Onset Bipolar Disorders Program, funded by the INSERM and the Assistance Publique Hôpitaux de Paris (APHP). Since 2007, he has led collaborative research programmes on genetic vulnerability factors in bipolar disorders and is currently conducting a prospective follow-up study on cognitive deficits and relapse risk factors in bipolar disorder. He received several research prizes: University Paris 12 Research Prize (2000), the Jules Baillarger Prize (2002) and the NARSAD Independent Investigator Award (2004). For the research program on biomarkers of lithium response, the National Research Agency (ANR générique), the Sorbonne Paris Cité University, the French Ministry of Research (PHRC) and the FondaMental/Dassault Fondations Research Prize (2013) fund his team.
More 200 publications (PubMed August 2016). H index=44
Professor Bellivier’s principal research interest relates to understanding the molecular basis of bipolar disorder and its treatment, and he has published widely in this area. His research is particularly focused on the genetic vulnerability factors in bipolar disorder and how to identify homogeneous subgroups of the disorder to improve the identification of biomarkers. Professor Bellivier is also involved in research on genetic vulnerability factors of suicidal behaviour and addictions.